Houston-based CRG, a healthcare-focused investment firm, has appointed Adam Whitehead as vice president of investor relations, according to a statement from the firm.
Whitehead brings more than 10 years of experience in asset allocation, manager due diligence and fundraising to the role. He joined CRG’s Colorado office in October from Crestone Capital Advisors, a multi-family office for ultra-high net worth entrepreneurs and executives, where he served as a senior investment analyst for nearly six years.
Prior to this he worked in senior research roles at financial advisory firms Sovereign Wealth Management, Quantitative Equity Systems, and the Bornhoft Group. He began his career as a proprietary trader and asset liability modeler at financial institution Branch Banking & Trust.
Whitehead’s hire comes as CRG, formerly known as Capital Royalty, seeks to raise $1 billion for its latest investment vehicle, CRG Partners III. The fund has raised $663 million so far, according to PEI data.
“Adam brings to CRG deep knowledge of the alternative investment landscape and a strong book of contacts to continue our rapid growth,” said Nate Hukill, president of CRG. “This exciting addition will help us better service our limited partners and expand on relationships with institutional investors that allocate to private capital investment strategies.”
The firm has already begun investing the fund. This year CRG has made financing commitments totalling $458 million, around 20 percent of which came from Fund III’s predecessor, the $805 million Capital Royalty Partners II, according to pfm sister title Private Healthcare Investor.
CRG, which was founded by Charles Tate in 2003 , manages almost $3 billion in assets across 42 healthcare investments. The firm focuses on underwriting senior secured loans to invest in companies across the healthcare sector.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: